No Result
View All Result
  • Home
  • Market Sectors
    • Technology
    • Health
    • Finance
    • Consumer
    • Commercial Services
    • Electronic
    • Communications
    • Transportation
    • Utilities
    • Minerals
    • Other Sectors
    • Electric Vehicles
    • Pot Stock
    • 5G Stock
    • Crypto
  • Stock Analyst News
  • Earnings News
  • Insider Trades
  • Dividend Stocks
Subscribe Now
  • Home
  • Market Sectors
    • Technology
    • Health
    • Finance
    • Consumer
    • Commercial Services
    • Electronic
    • Communications
    • Transportation
    • Utilities
    • Minerals
    • Other Sectors
    • Electric Vehicles
    • Pot Stock
    • 5G Stock
    • Crypto
  • Stock Buys
    • Strong Buys
    • Insider Buys
  • Insider Trades
  • Dividend Stocks
  • Event Calendars
    • Earnings and Dividend
    • IPO
  • Special Reports
No Result
View All Result
HOME MARKET SECTORS STOCK BUYS INSIDER TRADES DIVIDEND STOCKS
     BACK TO MENU Technology Health Finance Consumer Commercial Services Electronic Communications Transportation Utilities Minerals Other Sectors Electric Vehicles Pot Stock 5G Stock Crypto
politicsandmyportfolio.com
No Result
View All Result

Piper Sandler Analyst Reiterates Buy Rating on Iovance Biotherapeutics, IOVA

by Staff Editor
Jan 29, 2023
in healthcare stocks Analysts 
The scanners at marketmoveralerts.com, with the help of Tipranks.com, found the following stock rating has recently occurred.

Joseph Catanzaro
analyst at Piper Sandler reiterates coverage on Iovance Biotherapeutics (IOVA) in the Healthcare sector with a Buy rating. TipRanks.com has Catanzaro rated as a 4.3 star analyst with a 43% return on investment and a 10.2% success rate. Catanzaro has set a price target of $ 14.

TipRanks.com reports that Iovance Biotherapeutics currently has 10 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $22.78. The target pricing ranges from a high forecast of $38.00 down to a low forecast of $6.00. Iovance Biotherapeutics (IOVA)’s last closing price was $8.16 which would put the average price target at 179.17% upside.

In addition, TradingView issued a Buy rating for IOVA over the next month, Barchart.com has a Weak sell rating and Yahoo! Finance has a Bullish short-term outlook. Remember, securities are volatile, so please do your own research on IOVA.

One resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals.  Click here for more on Tipranks.com. Another great tool for charting is TradingView.com, so you might want to check that out too.

Click here to get the full story >>


When an analyst reiterates coverage on IOVA, we will let you know.  Please make sure you subscribe to our email newsletter to get timely alerts. Join thousands of other investors, you can always unsubscribe.

Disclaimer: Sandpiper Marketing Group, LLC would like to remind you the data contained in this website is not necessarily real-time nor accurate. All stocks, indexes, futures and Forex prices are not provided by exchanges but rather by our editor research at the time of writing this release, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Sandpiper Marketing does not bear any responsibility for any trading losses you might incur as a result of using this data. Sandpiper Marketing Group, LLC or anyone involved with Sandpiper Marketing Group, LLC will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in this website/newsletter is not trustworthy unless verified by their own research. Also, because events/circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.    
==============================================================================
Tags: Iovance Biotherapeutics stock IOVA IOVA price target Iovance Biotherapeutics analyst Healthcare stock watchlist 

Related Posts

Insider Trading inside trades stock analyst AEYE 

AEYE Showing Recent Insider Activity

Mar 20, 2023
Insider Trading inside trades stock analyst NOGN 

NOGN Showing Recent Insider Activity

Mar 20, 2023
Insider Trading inside trades PFMT PFMT price target stock 

PFMT Showing Recent Insider Activity

Mar 20, 2023
Basic Materials stock watchlist Basic Materials stocks Basic Materials movers Wheaton Precious Metals stock WPM 

2 Stocks Make It On Today's Mining & Metal Stock Watchlist 

Mar 20, 2023
financial stocks Financial stock watchlist Truist Financial stock Financial movers PNC Financial stock 

2 Stocks Make It On Today's Financial Stock Watchlist 

Mar 20, 2023
healthcare stocks Healthcare stock watchlist Healthcare movers Centene stock CNC 

2 Stocks Make It On Today's Healthcare & Biotech Stock Watchlist

Mar 20, 2023
Next Post
Canadian regulator rejects Enbridge plan to contract oil pipeline space

Canadian regulator rejects Enbridge plan to contract oil pipeline space

Nvidia’s DLSS has come to Linux gaming (but not the Steam Deck obviously)

Nvidia’s DLSS has come to Linux gaming (but not the Steam Deck obviously)

No Result
View All Result

Screener data might be 15 minutes delayed from the real time.

  • Sitemap
  • Newsletters
  • Advertise with Us
  • About Us
  • Feedback/Contact Us
  • Privacy Policy
  • Disclaimer

©2021 Sandpiper Marketing Group
PO Box 407. Mt. Mourne, NC 28123-0407

  • Home
  • Market Sectors
    • Technology
    • Health
    • Finance
    • Consumer
    • Commercial Services
    • Electronic
    • Communications
    • Transportation
    • Utilities
    • Minerals
    • Other Sectors
    • Electric Vehicles
    • Pot Stock
    • 5G Stock
    • Crypto
  • Stock Buys
    • Strong Buys
    • Insider Buys
  • Insider Trades
  • Dividend Stocks
  • Event Calendars
    • Earnings and Dividend
    • IPO
  • Special Reports

©2021 Sandpiper Marketing Group

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In